Related Experiment Video

Updated: Jul 19, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

[Long-term effects of environmental endocrine disruptors on male fertility]

C Mauduit1, A Florin, S Amara

  • 1Inserm U407, faculté de médecine Lyon-Sud, BP 12, 69 921 Oullins, France. mauduit@sante.univ-lyon1.fr

Gynecologie, Obstetrique & Fertilite
|September 26, 2006
PubMed

Insights

Environmental endocrine disruptors (EDs) may cause testicular dysgenesis syndrome (TDS), leading to male reproductive issues like infertility and genital malformations. Research explores EDs

Area of Science:

  • Reproductive Toxicology
  • Environmental Health
  • Endocrinology

Context:

  • Epidemiologic studies show rising rates of male reproductive disorders including testis cancer, cryptorchidism, hypospadias, and reduced sperm quality over 50 years.
  • These conditions are collectively termed testicular dysgenesis syndrome (TDS).
  • Intra-uterine exposure to endocrine disruptors (EDs) is hypothesized as a cause of TDS.

Purpose:

  • To establish a link between ED exposure and TDS.
  • To identify the underlying mechanisms of EDs' impact on testicular development.
  • To propose biomarkers for identifying fetal exposure to anti-androgenic EDs and subsequent male testicular pathology.

Summary:

  • Endocrine disruptors (EDs) are environmental compounds found in daily products that interfere with hormone metabolism.
  • Key mechanisms explored include epigenetic intergenerational transmission, programmed cell death of testicular cells, androgenic signal disruption, and the role of germ cell-Sertoli cell interactions.
  • The importance of the exposure window during fetal development is highlighted.

Impact:

  • Understanding the mechanisms linking EDs to TDS can inform preventative strategies.
  • Identification of biomarkers may aid in early detection and risk assessment for male reproductive pathologies.
  • This research contributes to public health by addressing environmental factors affecting male reproductive health.

More Related Videos

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Related Concept Videos

Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...